| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(00)82038-3 |
| P698 | PubMed publication ID | 10841143 |
| P50 | author | Everett E Vokes | Q73567428 |
| P2093 | author name string | A M Mauer | |
| P C Hoffman | |||
| P2860 | cites work | Transcarinal needle aspiration biopsy in the staging of lung cancer | Q72375012 |
| Incidence of local recurrence and second primary tumors in resected stage I lung cancer | Q72395348 | ||
| Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study | Q74784116 | ||
| Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer | Q77361527 | ||
| Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide | Q77912158 | ||
| Revisions in the International System for Staging Lung Cancer | Q28241070 | ||
| Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer | Q33329807 | ||
| Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial | Q33330612 | ||
| Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths | Q33856891 | ||
| Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group | Q33870498 | ||
| Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee | Q34065009 | ||
| Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer | Q40687767 | ||
| A meta-analysis of thoracic radiotherapy for small-cell lung cancer | Q41086687 | ||
| Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer | Q41616082 | ||
| Optimizing selection of patients for major lung resection | Q43969421 | ||
| Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life | Q44545383 | ||
| Global cancer statistics | Q44583516 | ||
| Survival after resection of stage II non-small cell lung cancer | Q46482962 | ||
| Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group | Q48341719 | ||
| Neurotoxicity in long-term survivors of small cell lung cancer | Q48373848 | ||
| Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group | Q48615331 | ||
| International differences in epidemiology of lung adenocarcinoma. | Q50955580 | ||
| Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. | Q51013426 | ||
| Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors. | Q52060856 | ||
| Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission | Q57665429 | ||
| Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer | Q59365257 | ||
| Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer | Q64381516 | ||
| Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer | Q67485777 | ||
| Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma | Q67486025 | ||
| Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party | Q69343080 | ||
| Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer | Q69844903 | ||
| Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung | Q69889426 | ||
| The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group | Q69910645 | ||
| Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial | Q70173226 | ||
| Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 | Q71961890 | ||
| Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients | Q72256266 | ||
| P433 | issue | 9202 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 479-485 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Lung cancer | |
| P478 | volume | 355 |
| Q28346531 | 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer |
| Q85203380 | A Novel Network Model for Molecular Prognosis |
| Q92424237 | A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis |
| Q28276647 | A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis |
| Q34747013 | A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial |
| Q34555834 | A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. |
| Q36553176 | A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report |
| Q28387995 | A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC |
| Q28388627 | A novel network model identified a 13-gene lung cancer prognostic signature |
| Q43740784 | A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer |
| Q34205843 | A prediction model for lung cancer diagnosis that integrates genomic and clinical features |
| Q41879747 | A rare case of lung cancer presenting as an ischioanal fossa mass |
| Q36324943 | Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements |
| Q38506598 | Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer. |
| Q31008766 | Advances in proteomic strategies toward the early detection of lung cancer |
| Q42277237 | Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer |
| Q34064494 | An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers |
| Q34169994 | Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma |
| Q40915441 | Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma. |
| Q35376683 | Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer |
| Q35068319 | Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC). |
| Q58120657 | Association of serum follistatin levels with histological types and progression of tumor in human lung cancer |
| Q40308418 | Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. |
| Q37972796 | Behavior of seeds and soil in the mechanism of metastasis: a deeper understanding |
| Q40939787 | Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial. |
| Q24324198 | Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer |
| Q41643045 | Bronchioloalveolar neoplasia. |
| Q24299910 | C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer |
| Q53654118 | CT-guided radiofrequency ablation of a bronchogenic carcinoma |
| Q40439589 | CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. |
| Q35732686 | Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer |
| Q37351199 | Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors |
| Q35178092 | Chinese herbal decoction based on syndrome differentiation as maintenance therapy in patients with extensive-stage small-cell lung cancer: an exploratory and small prospective cohort study |
| Q64229950 | Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo |
| Q90451931 | Classification of Pathological Types of Lung Cancer from CT Images by Deep Residual Neural Networks with Transfer Learning Strategy |
| Q35137739 | Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management. |
| Q54109548 | Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2. |
| Q37317171 | Clinical impact of high-throughput gene expression studies in lung cancer |
| Q91596373 | Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma |
| Q52656871 | Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer. |
| Q79550116 | Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer |
| Q55400908 | Clinically Significant Dysregulation of hsa-miR-30d-5p and hsa-let-7b Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer. |
| Q38813637 | Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis |
| Q37121374 | Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis |
| Q37124219 | Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis |
| Q34169194 | Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer |
| Q36774761 | Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR |
| Q51022866 | Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma. |
| Q34571974 | Combined chemotherapy and radiation in locally advanced non-small-cell lung cancer |
| Q35017970 | Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancer |
| Q34447507 | Combined modality treatment with chemotherapy and radiation in locally advanced non-small cell lung cancer |
| Q28388778 | Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer |
| Q28386520 | Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study |
| Q34075588 | Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma |
| Q84994479 | Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer |
| Q37820757 | Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC). |
| Q34313170 | Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model |
| Q23918759 | Confirmation of gene expression-based prediction of survival in non-small cell lung cancer |
| Q92648951 | Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma |
| Q34291456 | Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway |
| Q38983853 | Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway |
| Q53094833 | Cytodiagnostic aspects of lung adenocarcinoma manifesting with micropapillary pattern in sputum: a case report of potential diagnostic pitfall. |
| Q34145860 | Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis |
| Q41093098 | Detection of oncogenic mutations in resected bronchial margins by next-generation sequencing indicates early relapse in stage IA lung adenocarcinoma patients |
| Q54449968 | Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions. |
| Q36671434 | Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? |
| Q43697314 | Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro |
| Q36449835 | Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance |
| Q90647308 | Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies |
| Q43982169 | Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer |
| Q36694461 | Economics of the clinical management of lung cancer in France: an analysis using a Markov model |
| Q38792745 | Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells |
| Q43972336 | Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. |
| Q35870332 | Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study |
| Q92819792 | Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer |
| Q36584314 | Elevated microsatellite alterations at selected tetra-nucleotide (EMAST) in non-small cell lung cancers--a potential determinant of susceptibility to multiple malignancies |
| Q33854290 | Emphysema early diagnosis using X-ray diffraction enhanced imaging at synchrotron light source |
| Q38863283 | Epigenetic regulation of miR-129-2 and its effects on the proliferation and invasion in lung cancer cells |
| Q26996766 | Epigenetics of lung cancer |
| Q36095123 | Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis |
| Q40430704 | Expression and significance of SOX2 in non-small cell lung carcinoma |
| Q35759055 | Expression of aquaporin 5 in primary carcinoma and lymph node metastatic carcinoma of non-small cell lung cancer |
| Q78338960 | Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients |
| Q89668414 | Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report |
| Q39777394 | Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins. |
| Q35683636 | Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6 |
| Q28550689 | Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer |
| Q44645796 | Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. |
| Q37520347 | GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer |
| Q97419610 | GOLPH3 Promotes Angiogenesis of Lung Adenocarcinoma by Regulating the Wnt/β-Catenin Signaling Pathway |
| Q28082432 | Gastrointestinal hemorrhage due to ileal metastasis from primary lung cancer |
| Q43205388 | Gefitinib as first-line therapy for advanced or metastatic non-small cell lung cancer patients in southern Taiwan |
| Q36643732 | Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer |
| Q64379436 | Gene transfer into solid tumours--is a special application device beneficial? |
| Q37212218 | Genome-wide analysis of survival in early-stage non-small-cell lung cancer |
| Q34075693 | Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo |
| Q24814451 | HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC). |
| Q42026653 | HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1. |
| Q37215561 | Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry |
| Q37696123 | Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung |
| Q64230120 | High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells |
| Q79186097 | Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada |
| Q33815687 | Histone variant H3F3A promotes lung cancer cell migration through intronic regulation |
| Q34666257 | Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling |
| Q36634788 | Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity |
| Q23924046 | Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction |
| Q37076896 | Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma. |
| Q42430089 | Identification of Gene Biomarkers for Distinguishing Small-Cell Lung Cancer from Non-Small-Cell Lung Cancer Using a Network-Based Approach |
| Q36661979 | Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins. |
| Q92138268 | Identification of differentially expressed genes in small and non-small cell lung cancer based on meta-analysis of mRNA |
| Q34069325 | Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis. |
| Q61447507 | Identification of potential biomarkers of lung adenocarcinoma brain metastases via microarray analysis of cDNA expression profiles |
| Q37185019 | Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model |
| Q38840370 | Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma |
| Q34390851 | Image-guided radiofrequency tumor ablation: challenges and opportunities--part II. |
| Q37970168 | Imaging follow-up of RF ablation of lung tumours |
| Q33960866 | Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF. |
| Q37438558 | Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. |
| Q34360263 | Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer |
| Q34588391 | In vivo and in vitro antitumor effects of platycodin d, a saponin purified from platycodi radix on the h520 lung cancer cell |
| Q42324488 | Increase of the therapeutic effect on non-small-cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro |
| Q44582765 | Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas |
| Q40601896 | Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate |
| Q36548059 | Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo |
| Q35581358 | Initial surgical staging of lung cancer |
| Q28397049 | Integrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer Metastasis |
| Q38449984 | Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer. |
| Q33955214 | Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer |
| Q35909917 | Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population |
| Q33598513 | Iris metastasis as the first sign of small cell lung cancer: A case report |
| Q33455626 | Is genetic background important in lung cancer survival? |
| Q57788685 | Isoliquiritigenin inhibits cell proliferation and migration through the PI3K/AKT signaling pathway in A549 lung cancer cells |
| Q89507909 | Keratin 17 Promotes Lung Adenocarcinoma Progression by Enhancing Cell Proliferation and Invasion |
| Q33861693 | Label-free quantitative proteomics and N-terminal analysis of human metastatic lung cancer cells |
| Q80866788 | Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo |
| Q90174700 | LncRNA SNHG14 contributes to the progression of NSCLC through miR-206/G6PD pathway |
| Q45215488 | Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series |
| Q36148748 | Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. |
| Q35408328 | Lung cancer: district active treatment rates affect survival |
| Q36729428 | MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma. |
| Q37171914 | Mass spectrometry-based proteomic profiling of lung cancer |
| Q26751220 | Melatonin as a potential anticarcinogen for non-small-cell lung cancer |
| Q29614295 | Metastasis: from dissemination to organ-specific colonization |
| Q42857809 | Micro soft tissues visualization based on x-ray phase-contrast imaging |
| Q41347645 | MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value |
| Q33590325 | MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma |
| Q55255622 | MicroRNAs in Smoking-Related Carcinogenesis: Biomarkers, Functions, and Therapy. |
| Q38034647 | Mitochondrial dysfunction and cancer metastasis |
| Q60196643 | Modelos experimentais em oncologia: O contributo da cultura de células para o conhecimento da biologia do cancro |
| Q34467471 | Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases |
| Q37588387 | Molecular gene signature and prognosis of non-small cell lung cancer |
| Q42720667 | Molecular recognition of small-cell lung cancer cells using aptamers |
| Q64914336 | Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study. |
| Q39195707 | Multiple mutations of lung squamous cell carcinoma shared common mechanisms |
| Q82905302 | Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients |
| Q57070273 | Murrangatin suppresses angiogenesis induced by tumor cell-derived media and inhibits AKT activation in zebrafish and endothelial cells |
| Q60302147 | Next-generation sequencing of circulating tumor DNA for detection of gene mutations in lung cancer: implications for precision treatment |
| Q41919001 | Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC. |
| Q39139857 | Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer |
| Q37195118 | Nitric oxide and cancer therapy: the emperor has NO clothes |
| Q33829653 | Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer |
| Q27350219 | Non-invasive microstructure and morphology investigation of the mouse lung: qualitative description and quantitative measurement |
| Q34313101 | Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin |
| Q37874768 | Non-small-cell lung cancer. |
| Q28386773 | Novel insights into the molecular origins and treatment of lung cancer |
| Q40190611 | Ocular Metastasis in Lung Cancer: a Retrospective Analysis in a Single Chinese Hospital and Literature Review |
| Q37163460 | Ocular metastasis of lung adenocarcinoma with ELM4-ALK translocation: A case report with a review of the literature |
| Q53647324 | Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection. |
| Q78723639 | Outcomes and patterns of failure in bronchial carcinoid tumors |
| Q90317181 | Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning |
| Q35676367 | P42 Ebp1 functions as a tumor suppressor in non-small cell lung cancer |
| Q38792223 | PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair |
| Q47263279 | Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies |
| Q52807426 | Percutaneous radiofrequency ablation in the treatment of pulmonary malignancies: efficacy, safety and predictive factors. |
| Q33385378 | Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer |
| Q33419961 | Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations |
| Q47723850 | Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations |
| Q37225403 | Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition |
| Q92851498 | Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway |
| Q55345918 | Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis. |
| Q90236822 | Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment |
| Q82506977 | Predicting pulmonary adenocarcinoma outcome based on a cytology grading system |
| Q74092381 | Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma |
| Q28385873 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients |
| Q38732692 | Prognostic role of TPL2 in early‑stage non‑small cell lung cancer |
| Q34467221 | Prognostic value of CD133 expression in stage I lung adenocarcinomas |
| Q41593321 | Prognostic value of molecular events from negative surgical margin of non-small-cell lung cancer. |
| Q77530356 | Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung |
| Q38839326 | Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells |
| Q37089504 | Protein profiles associated with survival in lung adenocarcinoma |
| Q33785608 | Protein signature for non-small cell lung cancer prognosis |
| Q34447500 | Radiotherapy for non-small cell lung cancer |
| Q57460541 | Real world study of the continuation of bevacizumab beyond disease progression after first-line treatment containing bevacizumab in Chinese patients with advanced non-small cell lung cancer |
| Q38390164 | Recurrence after surgery in patients with NSCLC. |
| Q33710746 | Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer |
| Q80473351 | Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency |
| Q38462244 | Requirements for clinical PET: comparisons within Europe |
| Q47625733 | Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). |
| Q36382936 | Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction |
| Q30051796 | Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76 |
| Q64922653 | Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer. |
| Q53687949 | Role of long non-coding RNA in drug resistance in non-small cell lung cancer. |
| Q34214951 | Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma |
| Q36968924 | SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival |
| Q57478262 | SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target |
| Q59794398 | SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients |
| Q92366894 | STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/β‑catenin pathway and feedback regulation by c‑myc |
| Q93033591 | Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation? |
| Q38110297 | Seed, soil, and beyond: The basic biology of brain metastasis |
| Q64072795 | Sequence-dependent synergistic cytotoxicity of icotinib and pemetrexed in human lung cancer cell lines in vitro and in vivo |
| Q33278805 | Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population |
| Q35742690 | Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma |
| Q39659948 | Single cell phospho‐specific flow cytometry can detect dynamic changes of phospho‐Stat1 level in lung cancer cells |
| Q64240747 | Small bowel perforation with multiple intestinal metastases from lung carcinoma: A case report |
| Q37110783 | Small-cell lung cancer: 8 years experience of a single multidisciplinary team |
| Q39827649 | Smoking habits in elderly lung cancer patients: still no changes in epidemiology? A single-center experience |
| Q64235277 | Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling |
| Q99625040 | Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway |
| Q42211001 | Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report |
| Q73466972 | Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status |
| Q89924137 | Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis |
| Q35171191 | Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer |
| Q35052645 | TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis |
| Q85246015 | TS expression predicts postoperative recurrence in adenocarcinoma of the lung |
| Q59793506 | Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer |
| Q35575047 | The Role of Pemetrexed (Alimta®, LY231514) in Lung Cancer Therapy |
| Q39095803 | The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer |
| Q31048031 | The inhibition of lung cancer cell growth by intracellular immunization with LC-1 ScFv |
| Q23909716 | The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells |
| Q34499855 | The molecular genomics of metastatic brain tumours. |
| Q34692260 | The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma |
| Q81408492 | The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: the coexistence predicts a poor prognosis regardless of EGFR levels |
| Q96304930 | The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy |
| Q40407913 | The role of VATS in the staging of non small cell lung cancer |
| Q34322658 | The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis |
| Q35667675 | The role of gene expression profiling in early-stage non-small cell lung cancer |
| Q38211072 | The role of inflammation in lung cancer. |
| Q37044593 | The state of molecular biomarkers for the early detection of lung cancer |
| Q37077398 | Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression |
| Q39559573 | Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer |
| Q37460983 | Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma |
| Q73411410 | Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography |
| Q34434036 | Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry |
| Q47562619 | Toward the individualization of lung cancer therapy |
| Q37885347 | Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy |
| Q37512560 | Translating genomics into clinical practice: applications in lung cancer |
| Q34384453 | Trends and perspectives in multimodality therapy of locoregionally advanced non-small cell lung cancer |
| Q97644653 | Tumor Primary Location May Affect Metastasis Pattern for Patients with Stage IV NSCLC: A Population-Based Study |
| Q37633861 | Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas |
| Q36257504 | Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression |
| Q30796772 | Using protein microarray as a diagnostic assay for non-small cell lung cancer |
| Q92533452 | VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study |
| Q64108012 | Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
| Q24310644 | WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis |
| Q34352229 | Whole genome sequencing for lung cancer. |
| Q83867417 | Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in Queensland |
| Q36536565 | Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer |
| Q51746137 | [Epidemiological Evolution of Lung Cancer in the South of Spain from 1990 to 2010]. |
| Q74517772 | [Interventional diagnostic and therapeutic endoscopic ultrasonography] |
| Q80941589 | [Radiofrequency ablation of primary and secondary lung tumors: is the promise of this scalpel-free technique now a reality?] |
| Q84618309 | [Reason for a medical visit in the diagnosis of lung cancer. A review of 481 cases] |
| Q78524341 | [Usefulness of endoscopic ultrasound-guided fine needle aspiratioN (EUS-G FNA) in diagnosing the extension of non-small cell lung cancer] |
| Q64884710 | xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. |
Search more.